Grand Medical Group

About us

Grand Medical Group AG is a group of pharmaceutical companies specialized in the development, production, registration and introduction into medical practice of modern innovative products based on organic, synthetic and herbal compounds.

read more

10 Kornmarkt Street, CH - 6004 Luzern, Switzerland

info@grandmedicalgroup.ch

+41 415880810

CYSTOLIBERIN

KEY INGREDIENTS

D-mannose
Large cranberry (Vaccinium macrocarpon)standardized extract
Bearberry (Arctostaphylos uva-ursi)extract standardized by arbutin content

HEALTH BENEFITS OF USE

CYSTOLIBERIN is recommended as a health supplement to diet, which provides the most effective impact on prevention of recurrent urinary tract infection (including UTI during urolithiasis). D-mannose and extract of Vaccinium macrocarpon may hinder bacteria adhesion to the urothelium and extract of Uva-Ursi may act directly against most common pathogens (Staphylococcus aureus, Bacillus subtilis, Escherichia coli, Mycobacterium smegmatis, Shigella sonnei, Proteus mirabilis, and Pseudomonas aeruginosa). There is a vast statistical data confirming the usefulness and safety for every component in people with chronic infection of the Ureteral Tract.

AREAS OF APPLICATION – as a support

• In complex prevention of recurrent and chronic urinary tract infections such as cystitis, urethritis or pyelonephritis;

• In the complex treatment of patients with urolithiasis in adults for prevention of urinary tract infections;

• In complex therapy with purpose to reduce inflammation symptoms of mild recurrent lower urinary tract infections such as burning sensation during urination and/or frequent urination in adults;